发表文章：
Xiaochun Zhang, Shiqiang Hou, Weijing Liu, et al. Percutaneous Left Atrial Appendage Closure With a Novel LAA Occluder for Stroke Prevention in Atrial Fibrillation. JACC Asia. 2022 Oct; 2(5): 547–556.10.1016/j.jacasi.2022.04.009
刘伟静，马超，徐亚伟，吕中伟. 新支付模式下精准诊疗的探索——冠心病跨学科诊疗. 中国实用内科杂志. 2022,42(11):906-910. DOI: 10.19538/j.nk2022110107.
孙逸凡,刘伟静,徐亚伟. 移动医疗与⼼脏康复, 中国实用内科杂志. 2022,42(05):353-357. DOI: 10.19538/j. nk2022050101.
Liu Weijing, Fan Ximin, Shen Jianying, Zhu Mengyun, Fan Xuehua, Xu Yawei, et al. Cardiac Shock Wave Therapy Ameliorates Myocardial Ischemia in Patients With Chronic Refractory Angina Pectoris: A Randomized Trial. Front Cardiovasc Med. 2021; 8: 664433. (if=6.05)
刘伟静，孙玉玺，沈建颖，赵璇，徐亚伟.心脏康复的发展现状，中国研究型医院，2020,7,(2):82-85. Liu weijing, Sun yuxi, Shen jianying, Zhao xuan, Xu yawei. Present and future of cardiac rehabilitation. China research hospital, 2020,7, (2):207-211.
刘伟静, 沈建颖, 朱梦云, 等. 体外心脏震波系统在缺血性心脏病中的应用[J]. 中国心血管杂志, 2018, 23(3): 200-203. Liu WJ, Shen JY, Zhu MY, et al. Application of extracorporeal cardiac shock wave system in ischemic heart disease [J]. Chin J Cardiovasc Med, 2018, 23(3): 200-203.
Sanket Kumar Shukla, Weijing Liu, Kunal Sikder, Sankar Addya, Amrita Sarkar, Yidong Wei, Khadija Rafq1, et al. HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk. Sci Rep. 2017 ;7(1):4590（if=4.379）
刘伟静, 沈建颖, 朱梦云等.体外心脏震波治疗顽固性心绞痛的有效性和安全性，上海医学，2017, 40(4):206-209. LIU Weijing, SHEN Jianying, ZHU Mengyun, ZHANG Yi, FAN Xuehua, XU Yawei. Efficacy and safety of extracorporeal cardiac shock wave therapy for intractable angina. Shanghai Med J, 2017, Vol. 40, No.4.
Liu, W, Ming Q, Shen J, Wei Y, Li W, Chen W, Xu Y. et al. Trimetazidine Prevention of Contrast-Induced Nephropathy in Coronary Angiography. Am J Med Sci. 2015. Nov; 350(5): 398-402.（1.847）
Liu, W.J. Zhang BC, Guo R, Wei YD, Li WM, Xu YW. Renoprotective effect of alprostadil in combination with statins in patients with mild to moderate renal failure undergoing coronary angiography. Chin Med J (Engl), 2013. 126(18): p. 3475-80.（1.064）
Zhang, B.C, Liu WJ, Che WL, Xu YW, Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: a meta-analysis of 17 case-control studies. Clin Endocrinol (Oxf), 2012. 77(3): p. 370-8. （3.327）
刘伟静，张步春，徐亚伟.前列地尔对介入术后肾损伤保护作用的临床观察，实用医学杂志，2012, 17(9):2952-2953.
范希旻，刘伟静等，动态单光子发射计算机断层成像术在心血管疾病中的应用，中国介入心脏病学杂志 2019,27(7) :396-399.
Tang K, Zhao Y, Li H, Zhu M, Li W, Liu W, Zhu G, Xu D, Peng W, Xu YW, Translocase of Inner Membrane 50 Functions as a Novel Protective Regulator of Pathological Cardiac Hypertrophy. J Am Heart Assoc. 2017 Apr 21; 6(4).
Guo R, Liu W, Liu B, Zhang B, Li W, Xu Y. SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism. Int J Cardiol. 2015; 191:36-45.
Ban Liu, Wenliang Che, Changzhu Zheng, Weijing Liu, Jing Wen, Haitao Fu, Kai Tang, Jinying Zhang, Yawei Xu. SIRT5: A Safeguard Against Oxidative Stress-Induced Apoptosis in Cardiomyocytes. Cell Physiol Biochem. 32:1050-1059. 2013.
Guo R, Su Y, Yan J, Sun H, Wu J, Liu W, Xu Y. Fasudil improves short-term echocardiographic parameters of diastolic function in patients with type 2 diabetes withpreserved left ventricular ejection fraction: a pilot study. Heart Vessels. 2015; 30(1):89-97.
张步春,车文良,刘伟静,等.Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials[J].岭南心血管病杂志（英文版）,2010,(4):238-245,249.
张步春,刘伟静,李海玲, 等.中国汉族人群ATP结合盒转运子A1基因R219K多态性与冠心病关联研究的荟萃分析[J].中国动脉硬化杂志,2012,(8):744-748.
郭荣,李沅敏,孙辉,吴家康，刘伟静 等.组织多普勒对急性冠状动脉综合征患者左室舒张功能的评价作用[J].太阳成集团学报（医学版）,2012,(4):49-53.
明强,苏杨,刘伟静, 等.临床应用碘对比剂碘克沙醇致迟发药物不良反应及危险因素分析[J].中国循环杂志,2014,(11):903-906.
张步春,刘伟静,侯磊, 等.心脏再同步治疗起搏器与心脏再同步治疗除颤器对心力衰竭患者预后影响的荟萃分析[J].中华急诊医学杂,2011,(12):1316-1320.
科研项目：
1.上海市第十人民医院攀登人才项目，阿托伐他汀联合前列地尔在冠脉介入治疗中的肾脏保护作用，主持
2.心馨心血管健康基金会心脏康复与代谢治疗研究基金，体外心脏震波联合曲美他嗪改善心肌梗死后患者心肌灌注和心脏功能的临床研究，主持
3.上海市第十人民医院国家自然基金培育资助项目，GAS6通过MAPK途径介导肺血管重构的机制研究，主持
4.国家自然科学基金项目，51178320，基于室内健康照明需求的照度与光谱对人体昼夜节律影响研究，参与
5. 上海市科委“科技创新行动计划”医学创新研究项目：心脏体外震波治疗冠状动脉非阻塞性心肌梗死，主持
6. 上海市2020年度“科技创新行动计划”社会发展科技攻关项目：南极科考队员在站期间心肺功能评价研究，主要参与者
7. 上海市市级医院新兴前沿技术联合攻关项目：体外超声震波对缺血性心肌病患者心功能的改善，主要参与者
主笔与主要参与者完成共识撰写
心脏康复分级诊疗中国专家共识，中国医院协会心脏康复专业委员会，中国介入心脏病学杂志，2022: 8.30(8).
体外震波治疗冠心病中国专家共识，中国医师协会心血管内科医师分会，中国医院协会心脏康复专业委员会，中华心血管病杂志（网络版）2022:5.
